<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04671979</url>
  </required_header>
  <id_info>
    <org_study_id>DVO005-1-431-CEI969</org_study_id>
    <nct_id>NCT04671979</nct_id>
  </id_info>
  <brief_title>Serum Lactate in Acute Mesenteric Ischemia</brief_title>
  <official_title>Lactate Dehydrogenase, Bowel Necrosis and Mortality in Acute Mesenteric Ischemia: Retrospective Cross-Sectional</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universidad del Rosario</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universidad del Rosario</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Background: Acute mesenteric ischemia is a vascular emergency with high mortality because of&#xD;
      ambiguous symptomatology and a lack of early diagnostic markers. Lactate dehydrogenase has&#xD;
      been described as a mortality biomarker and bowel necrosis length too. Nevertheless, the&#xD;
      association between them has been mildly studied. Our objective was to evaluate the&#xD;
      association between serum lactate admission levels, bowel necrosis extension, and mortality.&#xD;
      Additionally, we performed a mortality characterization.&#xD;
&#xD;
      Materials and Methods: A retrospective cross-sectional study was designed. We reviewed&#xD;
      patients' clinical records with acute mesenteric ischemia that attended a hospital between&#xD;
      2012 and 2018. We compared serum lactate admission levels with bowel necrosis length and&#xD;
      mortality. A receiver operating characteristic curve was performed on the last association.&#xD;
      As post hoc analysis, a classification and regression tree on mortality was fitted.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 2, 2017</start_date>
  <completion_date type="Actual">June 30, 2020</completion_date>
  <primary_completion_date type="Actual">June 30, 2020</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <target_duration>30 Days</target_duration>
  <primary_outcome>
    <measure>Serum Lactate in mmol/l</measure>
    <time_frame>30 days</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Bowel necrosis length in cm</measure>
    <time_frame>30 days</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Percentage of patients that died between 30 postsurgical days, %</measure>
    <time_frame>30 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cut value of lactate levels as a predictor of mortality, in mmol/l</measure>
    <time_frame>30 days</time_frame>
    <description>A receiver operating characteristics curve</description>
  </secondary_outcome>
  <enrollment type="Actual">74</enrollment>
  <condition>Mesenteric Ischemia</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Lactate Dehydrogenase</intervention_name>
    <description>All the patients that arrived at the hospital with symptoms of mesenteric ischemia, had a registered lactate dehydrogenase. We compared the value with the patient's outcomes.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Seventy-four cases were identified that met the study's criteria. The patients' average age&#xD;
        was 73.5 (SD, 10.7) years, and 44 (60%) were men. The mean body mass index was 25 (SD, 2.9)&#xD;
        kg/m2. Fifteen (20%) of the patients presented non-occlusive acute mesenteric ischemia.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Older than 18 years of age&#xD;
&#xD;
          -  Required urgent laparotomy with a postoperative diagnosis of acute mesenteric ischemia&#xD;
&#xD;
          -  Attended the private academic hospital, between 2012 and 2018&#xD;
&#xD;
          -  Had a registered serum lactate dehydrogenase at admission&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Secondary causes of AMI&#xD;
&#xD;
          -  Chronic intestinal ischemic&#xD;
&#xD;
          -  Patient records with no description of the serum lactate dehydrogenase or extension of&#xD;
             intestinal necrosis&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Andres Isaza Restrepo</name>
      <address>
        <city>Bogotá</city>
        <state>Cundinamarca</state>
        <zip>111221</zip>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Colombia</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>December 3, 2020</study_first_submitted>
  <study_first_submitted_qc>December 11, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 17, 2020</study_first_posted>
  <last_update_submitted>December 11, 2020</last_update_submitted>
  <last_update_submitted_qc>December 11, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 17, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universidad del Rosario</investigator_affiliation>
    <investigator_full_name>Andrés Isaza Restrepo</investigator_full_name>
    <investigator_title>MD, MSc</investigator_title>
  </responsible_party>
  <keyword>Biomarker</keyword>
  <keyword>L-Lactate</keyword>
  <keyword>Mortality</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mesenteric Ischemia</mesh_term>
    <mesh_term>Ischemia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>We don't plan to share de IPD.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

